as on December 6, 2025 at 2:29 am IST
Day's Low
Day's High
1.88%
Downside
0.14%
Upside
52 Week's Low
52 Week's High
27.39%
Downside
67.39%
Upside
Check Novavax, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$1.1B
EPS (TTM)
2.1486
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
-0.38%
PE Ratio (TTM)
3.41
Industry PE ratio
-0.4116938110749186
PEG Ratio
0EBITDA
451.8M
Revenue (TTM)
1.1B
Profit Margin
32.10%
Return On Equity TTM
-898.20%
Track how Novavax, Inc. P/E has moved over time to understand its valuation trends.
Novavax, Inc. in the last 5 years
Lowest (-21.52x)
March 31, 2021
Industry (-0.41x)
December 6, 2025
Today (3.41x)
December 6, 2025
Highest (3.13x)
March 31, 2025
Today’s Price to Earnings Ratio: 3.41x
Compare market cap, revenue, PE, and other key metrics of Novavax, Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $1.1B | -94.53% | 3.41 | 32.10% | |
| BUY | $43.5B | 408.22% | -16.34 | -264.83% | |
| BUY | $61.5B | 253.6% | 1661.93 | 1.36% | |
| BUY | $117.3B | 99.49% | 32.16 | 31.35% | |
| BUY | $76.6B | 45.87% | 17.31 | 32.13% |
The Novavax, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Novavax, Inc. investment value today
Current value as on today
₹83,120
Returns
Returns from Novavax, Inc. Stock
Dollar Returns*
₹5,939 (+5.94%)
Based on 12 analysts
66.67%
Buy
16.67%
Hold
16.67%
Sell
Based on 12 analysts, 66.67% of analysts recommend a 'BUY' rating for Novavax, Inc.. Average target price of $12.67
Get share price movements and forecasts by analysts on Novavax, Inc..
What analysts predicted
45.54%UPSIDE
Target Price
$12.67
Current Price
$6.9
Analyzed by
12 Analysts
Target
$12.67
Novavax, Inc. target price $12.67, a slight upside of 45.54% compared to current price of $6.9. According to 12 analysts rating.
Search interest for Novavax, Inc. Stock has increased by 71% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:71% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 19 November
Thu, 00:36 AM
-Novavax focuses on strategic partnerships and Matrix-M platform to enhance vaccine commercialization and address unmet needs in infectious diseases.
Thu, 02:04 AM
-Notable options trading activity in Novavax with 22,231 contracts traded, indicating strong investor interest.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Against Peers
![]()
In the last 1 year, Insmed Incorporated has given 170.6% return, outperforming this stock by 193.3%
Against Peers
![]()
In the last 3 years, Insmed Incorporated has given 995.0% return, outperforming this stock by 1055.1%
Profit Down
![]()
Netprofit is down for the last 3 quarters, 518.64M → -202.37M (in $), with an average decrease of 184.7% per quarter
Revenue Fall
![]()
Revenue is down for the last 3 quarters, 666.65M → 70.44M (in $), with an average decrease of 67.3% per quarter
Price Dip
![]()
In the last 3 years, NVAX stock has moved down by -60.1%
| Organisation | Novavax, Inc. |
| Headquarters | 700 Quince Orchard Road, Gaithersburg, MD, United States, 20878 |
| Industry | Health Technology |
| CEO | Mr. John Charles Jacobs M.B.A. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Ms. Erika S. Trahan | Associate Director of Investor & Public Relations |
Mr. Ian J. Watkins | Executive VP & Chief Human Resources Officer |
Dr. Henrietta Ukwu FACP FRAPS, M.D. | Executive VP & Chief Regulatory Officer |
Mr. Richard P. Crowley | Executive VP & COO |
Mr. Troy Morgan Esq., J.D. | Senior VP, Deputy General Counsel & Chief Compliance Officer |
Ms. Silvia Taylor M.B.A. | Executive VP, Chief Corporate Affairs Officer & Head of Novavax Sweden |
Mr. John Charles Jacobs M.B.A. | President, CEO & Director |
Mr. James Patrick Kelly C.F.A. | Executive VP, CFO & Treasurer |
Mr. Mark J. Casey Esq. | Executive VP, Chief Legal Officer & Corporate Secretary |
Ms. Elaine O'Hara | Executive VP & Chief Strategy Officer |
Novavax, Inc. share price today is $6.9 as on at the close of the market. Novavax, Inc. share today touched a day high of $6.91 and a low of $6.77.
Novavax, Inc. share touched a 52 week high of $11.55 on and a 52 week low of $5.01 on . Novavax, Inc. stock price today i.e. is closed at $6.9,which is 40.26% down from its 52 week high and 37.72% up from its 52 week low.
Novavax, Inc. market capitalisation is $0.00T as on .
Indian investors can start investing in Novavax, Inc. (NVAX) shares with as little as ₹89.896 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹898.96 in Novavax, Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Novavax, Inc. share’s latest price of $6.9 as on December 6, 2025 at 2:29 am IST, you will get 1.4493 shares of Novavax, Inc.. Learn more about
fractional shares .
Novavax, Inc. stock has given -94.53% share price returns and 21.76% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?